Insiders bought these stocks heavily in 2025, but investors should be wary; only some of them are good buys for 2026 portfolios.
Partnership will Expand Shoulder Innovations' Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC
GRAND RAPIDS, Mich. , Nov. 19, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming...
GRAND RAPIDS, Mich. , Nov. 11, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused...
GRAND RAPIDS, Mich. , Nov. 4, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming...
GRAND RAPIDS, Mich. , Oct. 20, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming...
Insiders are buying these three healthcare companies that have catalysts to drive their share prices higher in the upcoming years.
Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio
Company to Participate in a Fireside Chat at the Morgan Stanley 23 rd Annual Global Healthcare Conference Today at 8:30 a.m. ET
Company to Participate in the Morgan Stanley 23 rd Annual Global Healthcare Conference on the Same Day